TRAF2 is a well-known regulator protein of TNFα-NFκB signaling, shown to be enriched in the GSEA analysis of lung cancer patients with KEAP1 mutation in sites R320 and R470 (Fig. 1D and E). The gene discussed is TRAF2; the disease is lung carcinoma.